Posted Two Blokes
byVerve Therapeutics (VERV) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimat
Source: Two Blokes Trading
Posted Two Blokes
byARS Pharmaceuticals, Inc. (SPRY) came out with a quarterly loss of $0.35 per share in line with the Zacks Cons
Source: Two Blokes Trading
Posted Two Blokes
byChicago Atlantic BDC, Inc. (LIEN) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus
Source: Two Blokes Trading
Posted Two Blokes
byBitfarms Ltd. (BITF) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estima
Source: Two Blokes Trading
Posted Two Blokes
by/ NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / TORONTO,
Source: Two Blokes Trading
Posted Two Blokes
byLive webcast followed by an interactive Q&A session on Thursday, May 22 nd at 4:00 PM ET
Source: Two Blokes Trading
Posted Two Blokes
byIOSP sees strong results in the Fuel Specialties unit in Q1 with higher margins driving a double-digit year-ov
Source: Two Blokes Trading
Posted Two Blokes
byWhile NUE gains on its actions to grow through acquisitions and capacity expansion, weak steel prices weigh on
Source: Two Blokes Trading
Posted Two Blokes
bySTRT, MNRO and SWX made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 14, 2025.
Source: Two Blokes Trading
Posted Two Blokes
byA relatively in-line inflation print for April did little to reassure markets about the economic path looking
Source: Two Blokes Trading
Posted Two Blokes
byMilestone advances process ahead of the special meeting of Shyft shareholders on June 17, 2025 NOVI, Mich. , M
Source: Two Blokes Trading
Posted Two Blokes
byMicrosoft is cutting less than 3% of its global workforce, including at LinkedIn. The company employed an esti
Source: Two Blokes Trading